Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
650 |
|
| Actual shortage: | 13 (2%) | |
| Anticipated shortage: | 6 (1%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (84%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
82 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-MONTELUKAST | 10MG | TABLET | Resolved | 2017-04-13 | 2017-12-08 | 7055 |
| MYLAN-NITRO PATCH 0.6 | 62.2MG | PATCH (EXTENDED RELEASE) | Avoided shortage | 2017-03-23 | 2017-12-20 | 4086 |
| MYLAN-ESCITALOPRAM | 10MG | TABLET | Resolved | 2017-10-13 | 2017-12-21 | 25885 |
| MYLAN-BACLOFEN | 10MG | TABLET | Resolved | 2017-10-26 | 2018-01-09 | 27072 |
| MYLAN-INDAPAMIDE | 2.5MG | TABLET | Avoided shortage | 2017-04-19 | 2018-01-26 | 7289 |
| MYLAN-ACEBUTOLOL (TYPE S) | 100MG | TABLET | Resolved | 2017-04-07 | 2018-02-02 | 5987 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2017-06-21 | 2018-02-03 | 13532 |
| MYLAN-LAMOTRIGINE | 25MG | TABLET | Avoided shortage | 2018-01-19 | 2018-02-08 | 36703 |
| MOVISSE | 0.35MG | TABLET | Avoided shortage | 2017-10-18 | 2018-02-09 | 26211 |
| MYLAN-AMLODIPINE | 10.0MG | TABLET | Resolved | 2017-11-03 | 2018-02-10 | 28029 |
| MYLAN-AMLODIPINE | 5.0MG | TABLET | Resolved | 2017-11-08 | 2018-02-10 | 28616 |
| MYLAN-FAMOTIDINE | 40MG | TABLET | Resolved | 2017-04-04 | 2018-02-15 | 5341 |
| MYLAN-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2017-05-05 | 2018-02-15 | 9241 |
| MYLAN-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-04-07 | 2018-02-15 | 5951 |
| MYLAN-RISPERIDONE | 0.50MG | TABLET | Resolved | 2017-10-23 | 2018-02-15 | 26702 |
| MYLAN-SERTRALINE | 25MG | CAPSULE | Avoided shortage | 2017-11-23 | 2018-02-15 | 30402 |
| MYLAN-SERTRALINE | 100MG | CAPSULE | Avoided shortage | 2017-11-23 | 2018-02-15 | 30359 |
| MYLAN-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-05-05 | 2018-02-15 | 9195 |
| MYLAN-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-04-07 | 2018-02-15 | 5990 |
| MYLAN-CLOBETASOL SCALP APPLICATION | 0.05% | LOTION | Resolved | 2017-08-10 | 2018-02-23 | 18684 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Discontinued | 2024-05-08 | 2024-05-08 | 227338 |